OHRP issues guidance on COVID-19
13 April 2020 by CITI Program

On April 8, 2020, the Office for Human Research Protections (OHRP) issued guidance on the regulatory requirements of 45 CFR 46 and actions taken during…

Scale Training to Help Staff Take on Research Roles
22 April 2020 by CITI Program

Although most research is paused during the global pandemic, there are new COVID-19 research studies starting every day. During this time, organizations may need to…

Technology Use to Manage Patient Care in the Era of COVID-19
10 April 2020 by CITI Program

An article this week in Wired Magazine outlined how physicians and other health care providers in hospitals are using technology to manage patient care in…

Guidance Issued on Defending Against VTC Hijacking and Zoom-bombing
7 April 2020 by CITI Program

The Cybersecurity and Infrastructure Security Agency (CISA) has published an article detailing steps to improve cybersecurity for video-teleconferencing (VTC) platforms. It also recommends several other…

OCR Bulletin: Civil Rights, HIPAA, and the Coronavirus Disease 2019 (COVID-19)
31 March 2020 by CITI Program

On March 28, 2020, the Health and Human Services Office for Civil Rights in Action (OCR) issued the bulletin Civil Rights, HIPAA, and the Coronavirus…

CITI Program’s Contribution to Health Literacy in Research
31 March 2020 by CITI Program

CITI Program continues to encourage the adoption of health literacy in research. Our Associate Director of Content and Education, Margaret Rankovic, is currently participating in…

Apps Being Developed to Improve Clinical Care
19 March 2020 by CITI Program

Mobile app research is growing in both medical and social-behavioral-educational fields of research. For example, bedside apps are being studied to see how they can…

Preparing for COVID-19, Impacts on Research Organizations
18 March 2020 by CITI Program

The rapidly evolving federal, state, and local policies regarding COVID-19 are impacting every walk of life in the United States and around the world. Companies,…

COVID-19 Vaccine Phase 1 Trial Begins
17 March 2020 by CITI Program

NIH is conducting a Phase 1 clinical trial of a new vaccine for COVID-19. Phase 1 research is the first clinical trial phase conducted with…

Time to revisit your disaster plan?
11 March 2020 by CITI Program

Introduction COVID-19 dominates daily news headlines as communities and organizations evaluate policies regarding public gatherings, quarantines, and other issues. Many states, including New York and…

Research During Global Health Emergencies
9 March 2020 by CITI Program

Complying with research ethics is notably challenging during global health emergencies such as the outbreak of coronavirus disease (COVID-19). Investigators must have an ethical framework…

U.S. Federal Regulatory Agencies Provide Guidance for Clinical Trials in Response to COVID-19
24 March 2020 by CITI Program

As COVID-19 continues to impact research organizations and clinical sites, federal agencies are issuing guidance for clinical trials. Organizations are closing or dramatically reducing operations…